Failed Trial Without Catheter Post Rezūm in Non-Catheter Dependent Patients: Risk Factors From the Canadian Rezūm Registry.

Key Points

• To identify risk factors for trial without catheter (TWOC) failure post Rezūm therapy in non-catheter dependent patients.
• Analyzed data from the Canadian Rezūm Registry.
• Examined rates of TWOC failure in non-catheter dependent patients after Rezūm therapy.
• Assessed baseline International Prostate Symptom Score (IPSS) as a potential risk factor.
• Approximately 25% of patients experienced TWOC failure after Rezūm therapy.
• High baseline IPSS was linked to increased risk of TWOC failure.
• Despite TWOC failures, overall urinary symptoms improved in all patients.